T1	Treatment 15 53	dose-escalated and accelerated regimen
T2	Treatment 83 92	COPP/ABVD
T3	Treatment 315 340	standard polychemotherapy
T4	Treatment 416 563	novel bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone (BEACOPP) scheme (standard and escalated dose)
T5	Treatment 582 709	cyclophosphamide, vincristine, procarbazine, and prednisone (COPP)/doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD).
T6	Treatment 901 910	COPP/ABVD
T7	Treatment 1027 1122	cyclophosphamide, doxorubicin, and etoposide with granulocyte colony-stimulating factor (G-CSF)
T8	Treatment 1144 1156	chemotherapy
T9	Treatment 1465 1474	COPP/ABVD
T10	Treatment 1586 1593	BEACOPP
T11	Treatment 1661 1668	BEACOPP
T12	Treatment 1749 1756	BEACOPP
T13	Treatment 1865 1872	BEACOPP
T14	Treatment 1891 1901	COPP/ABVD;
T15	Treatment 1912 1919	BEACOPP
T16	Treatment 2018 2025	BEACOPP
T17	Treatment 2095 2104	COPP/ABVD
